- No, a GLP-1 supplement does not work like a GLP-1 medication. The labels we reviewed don't list any GLP-1 drug, and the supplement’s main ingredients led to small or uncertain weight loss in studies.
- Your body’s own GLP-1 has a half-life of about 1 to 2 minutes, so any boost to it is brief. Prescription GLP-1 drugs are built to last much longer, with a half-life of about 5 days to 1 week.
- The U.S. Food and Drug Administration (FDA) doesn't approve supplements for safety or effectiveness before they're sold. One "GLP-1" product we reviewed contained caffeine and yohimbine, stimulants that can cause a faster heart rate, anxiety and higher blood pressure.
- If you take a GLP-1 medication, experts say vitamin D, calcium, vitamin B12, or protein supplements may help fill nutrient gaps, depending on your diet. They don’t cause weight loss themselves.
Since GLP-1 drugs like Wegovy® (semaglutide) and Zepbound® (tirzepatide) became popular, many supplements have added "GLP-1" to their names often with promises to curb hunger or cravings.
We checked what these products actually contain and what the research shows. Read on to see how they compare with the real medicines.
Do GLP-1 supplements work like GLP-1 medications?
No, GLP-1 supplements don't come close to the weight loss seen with GLP-1 medications. In clinical trials, the medicines led to about 11% to 21% weight loss. The supplement ingredients led to anywhere from no weight loss to about 8 pounds (less than 4% for a 220-pound person), and many results are uncertain.
| Product or ingredient | What studies found | FDA-approved for weight loss? |
|---|---|---|
| Zepbound® (tirzepatide), 15 mg shot | 20.9% of body weight lost in 72 weeks, vs 3.1% with a placebo | Yes (prescription) |
| Wegovy® (semaglutide), 2.4 mg shot | 14.9% lost in 68 weeks, vs 2.4% with a placebo | Yes (prescription) |
| Foundayo (orforglipron), 17.2 mg pill | 11.1% lost in 72 weeks, vs 2.1% with a placebo | Yes (prescription) |
| Berberine | Lost about 2 pounds (0.88 kg) more than comparison groups, across 23 studies | No |
| Green tea | About 3 pounds (1.25 to 1.36 kg), with low confidence in the results | No |
| glucomannan | Mixed: about 3 pounds (1.27 kg) more than a placebo in one large review, which the authors called too small to matter clinically. Another review of 8 trials found no real difference. | No |
| Psyllium fiber | Mixed: about 8 pounds (3.70 kg) in one large review, no weight loss in another | No |
| Akkermansia probiotic | About 5 pounds (2.27 kg) in 32 people, a result that could have been due to chance | No |
A placebo is an inactive pill or shot with no medicine in it, used for comparison. To put the numbers in perspective, a 220-pounds person who loses 15% of their weight, about what Wegovy® users lost, would lose about 33 pounds.
Why can't a supplement copy a GLP-1 drug?
A supplement can't copy a GLP-1 drug because it doesn’t contain a long-acting GLP-1 medicine. Supplements can only rely on your body's own GLP-1, which wears off within minutes. GLP-1 is a hormone your gut releases after you eat. It helps control blood sugar and makes you feel full.
Your body breaks down its own GLP-1 in about 1 to 2 minutes. Drug makers designed GLP-1 medicines to resist that breakdown so they last much longer. Semaglutide has a half-life (the time it takes your body to clear half of it) of about a week, and tirzepatide about 5 days.
Supplements that claim to "boost" GLP-1 aim to make your gut release a little more of your own hormone. However, these supplements can’t change how quickly your body clears it, so any extra GLP-1 is gone within minutes.
The research behind these claims is also thin. For example, studies showing berberine raises GLP-1 were done in rats and in lab-grown cells, not in people.
What's actually in GLP-1 supplements?
We reviewed 13 supplement labels in the National Institutes of Health (NIH) Dietary Supplement Label Database that use “GLP-1” in their name or marketing. Most contain plant extracts, fiber, probiotics (live "good" bacteria), or vitamins and minerals.
The most common ingredients were chromium, fiber, berberine, green tea extract, and probiotics, including a type called Akkermansia. One product also had caffeine and yohimbine, which are stimulants. Another label even stated, "Does not contain GLP-1."
Here's what the NIH says about common ingredients, based on its review of weight-loss studies.
| Ingredient | Effect on weight (NIH) | Safety notes (NIH) |
|---|---|---|
| Chromium | Minimal effect | No safety concerns at recommended amounts |
| Green tea extract | Possible modest effect | Liver damage has been reported with the extract |
| Caffeine | Possible modest effect | Safety concerns above 400 to 500 mg a day |
| Glucomannan (a fiber) | Little to no effect (about 3 pounds at most, with low confidence) | Tablet forms can get stuck in the throat or esophagus |
| Probiotics | Inconsistent effects | No safety concerns in healthy people |
| Yohimbe (yohimbine) | No effect | Serious risks, including fast heart rate, heart attack, and death |
The labels we reviewed used phrases like "Silence food noise" and "Potentiate GLP-1 production." By law, a supplement that makes this kind of claim must also carry a disclaimer saying the FDA hasn't evaluated the claim and that the product isn't intended to diagnose, treat, cure, or prevent any disease.
Do GLP-1 probiotics or berberine work?
Neither GLP-1 probiotics nor berberine has strong evidence for weight loss. Many of the studies are small, short, or funded by the companies that make the products.
In a 2019 study of Akkermansia, 32 adults completed 3 months of treatment with the probiotic or a placebo. The group taking a heat-treated (pasteurized) form of the bacteria lost about 5 pounds more than the placebo group, but the difference could have been due to chance. Several of the study’s researchers were named as inventors on patent applications related to the bacteria.
In a 2020 study 76 adults with type 2 diabetes were randomly assigned to a five-strain probiotic that included Akkermansia, a different probiotic formula, or a placebo for 12 weeks. Only 23 of them took the five-strain probiotic. Blood sugar after meals improved in the group taking the five-strain probiotic, but body weight didn’t change. All of the study's authors were employees of Pendulum Therapeutics, the company that sells the probiotic.
A 2026 review of 23 berberine studies found that people taking the supplement lost about 2 pounds more than comparison groups. The authors flagged common weaknesses, such as participants knowing whether they were taking berberine and studies not reporting how pure the product was.
Are GLP-1 supplements safe?
GLP-1 supplements aren’t guaranteed to be safe, because unlike drugs, dietary supplements don't need FDA review or approval before they reach stores.
Some ingredients carry serious risks. The NIH links yohimbine to a fast heart rate, heart attack, and death. It links green tea extract to liver damage. Glucomannan tablets can get stuck in the throat or esophagus.
Counterfeit and unapproved GLP-1 drugs sold online are another danger. The FDA has found counterfeit Ozempic® (semaglutide) in the U.S. It has also warned companies selling semaglutide and tirzepatide labeled "for research purposes" or "not for human consumption." These products may contain the wrong amount of the drug, the wrong drug, or none at all.
Some products sold as supplements also contain hidden prescription drugs. FDA labs have found hundreds of weight-loss products sold as dietary supplements that contained sibutramine. Sibutramine is a prescription drug that was withdrawn from the U.S. market in 2010 because it raised the risk of heart attack and stroke.
The FDA urges people not to buy unapproved GLP-1 products. Get GLP-1 medicines only with a prescription and only from a state-licensed pharmacy. Our guide on how to tell if a GLP-1 provider is legit lists warning signs.
What should you check on a GLP-1 supplement label?
When you read a GLP-1 supplement label, check four things: the FDA disclaimer, stimulants, red-flag claims, and whether the ingredients have been studied in people.
- The FDA disclaimer: Supplements that make health claims must carry a sentence saying the FDA hasn't evaluated those claims. It means no one checked whether the product works before it went on sale. A product that makes health claims without this sentence is breaking the FDA rules..
- Stimulants: Check for caffeine or yohimbine. The NIH reports significant safety concerns with yohimbine including high blood pressure, increased heart rates and heart attacks. Up to 400 mg of caffeine a day is considered safe for healthy adults, so check how much a daily dose contains.
- FDA red flags: The FDA warns about "quick fix" promises like "Lose 30 pounds in 30 days" and "all natural" labels used to suggest a product is safer than medicine. Personal success stories are another red flag, since they're easy to make up.
- Human research: Check whether the main ingredients have been studied in people. Some GLP-1 claims rest only on animal or lab studies. Berberine, for example, has weight-loss trials in people, but its effect on GLP-1 was shown mainly in rats and lab cells.
If a supplement causes a bad reaction, report it to the FDA through MedWatch or by calling 1-800-FDA-1088.
Can you buy GLP-1 pills over the counter?
No, you can't buy GLP-1 pills over the counter. FDA-approved GLP-1 pills for weight loss, such as the Wegovy® pill (semaglutide) and Foundayo (orforglipron), need a prescription. See our guide on how to get a GLP-1 prescription online.
The FDA approved Foundayo on April 1, 2026. In its main study, people taking the highest dose lost 11.1% of their body weight in 72 weeks, compared with 2.1% on a placebo.
What supplements might help if you take a GLP-1 medication?
If you take a GLP-1 medication, vitamin D, calcium, vitamin B12, or protein supplements may help, depending on your diet. A 2025 advisory from four obesity and nutrition groups says supplements can be considered for these nutrients, based on each person's needs.
| Nutrient | Daily target for adults | Food sources |
|---|---|---|
| Calcium | 1,000 mg; 1,200 mg for women over 50 and everyone over 70 | Milk, yogurt, cheese, canned salmon with bones |
| Vitamin D | 600 IU (15 mcg); 800 IU (20 mcg) for adults over 70 | Fatty fish (salmon, trout, tuna), fortified milk and plant milks |
| Vitamin B12 | 2.4 mcg | Meat, fish, eggs, dairy, and fortified plant foods |
| Protein | 1.2 to 1.6 g per kilogram of body weight during weight loss | Fish, eggs, Greek yogurt, cottage cheese |
Vitamin B12 deserves extra attention if you also take metformin, a common diabetes medicine. The NIH says metformin might lower how much B12 your body absorbs. Calcium, vitamin D, and vitamin B12 targets are from the NIH. The protein range is from the 2025 advisory.
Age matters too. Many older adults absorb less B12 from food, so the NIH says people over 50 should get most of their B12 from fortified foods, like some breakfast cereals, or supplements.
Protein shakes can help if a smaller appetite makes it hard to get enough protein from food, but protein alone may not protect your muscles. The same advisory recommends strength training at least 3 times a week. Our guide to protein powder for weight loss explains how to pick one.
Constipation is a common GLP-1 side effect. To ease it, the NIH suggests eating more high-fiber foods and getting regular physical activity. Most adults need 22 to 34 g of fiber a day.
If you eat more high-fiber foods or take a fiber supplement, drink plenty of water. See our guide to GLP-1 constipation.
If you take the Wegovy® pill, its label says to take it in the morning on an empty stomach with no more than 4 ounces of water, then wait at least 30 minutes before eating, drinking, or taking other medicines by mouth. Ask your pharmacist when to take your supplements.
When to see a healthcare provider
The FDA advises talking to a healthcare provider or pharmacist before taking any supplement, including GLP-1 supplements. Tell them about every supplement and medicine you use. If you're thinking about a GLP-1 medicine, a provider can tell you whether you qualify.
Call 911 or go to the nearest emergency room if you have chest pain, a fast or irregular heartbeat, or trouble breathing after taking a supplement.
Bottom line
- The GLP-1 supplements we reviewed don't contain GLP-1 drugs and don't work like them. Their ingredients led to small or uncertain weight loss in studies, and some carry real risks.
- If you want the effects of a GLP-1 drug, the options with strong evidence are prescription medicines. Learn more on our obesity treatment hub or compare Wegovy® vs Zepbound®.
How we source this
We rely on primary sources, including FDA labels, clinical trial registries, and peer-reviewed research. Read our editorial policy.
Related reading
- [GLP-1 side effects](https://peptides.io/learn/glp-1-side-effects-what-to-expect/) what's common and what helps.
Frequently asked questions
Is there a supplement that acts like GLP-1?
No supplement acts like a GLP-1 drug. Some ingredients may make your gut release a little more of its own GLP-1, but half of it is broken down within 1 to 2 minutes. Weekly GLP-1 injections, such as Wegovy® and Zepbound®, have a half-life of about 5 days to 1 week.
What is the best GLP-1 supplement for weight loss?
No GLP-1 supplement has strong proof of weight loss.
In studies, the best-researched ingredients, like berberine and green tea, led to about 2 to 3 pounds more weight loss than a placebo. The FDA-approved GLP-1 medicines led to about 11% to 21% weight loss, or about 22 to 42 pounds for someone who weighs 200 pounds. If you still want to try a supplement, check the label for stimulants and red-flag claims first.
Is berberine as good as Ozempic®?
No, berberine is far less effective than Ozempic® (semaglutide). Berberine led to about 2 pounds of extra weight loss across 23 studies. Ozempic® is FDA-approved for type 2 diabetes, and the same drug at weight-loss doses, Wegovy®, led to 14.9% weight loss in its main trial, compared with 2.4% on placebo.
Are there natural ways to boost GLP-1?
Yes, eating a meal naturally makes your gut release GLP-1, but your body breaks it down in minutes. Food alone won't match a GLP-1 drug. See our GLP-1 eating plan.
Can you take supplements with Wegovy® or Zepbound®?
Yes, many people can, but check with your provider first. Experts say vitamin D, calcium, vitamin B12, or protein may help some people on GLP-1 medicines. Don't take a "GLP-1" supplement on top of a GLP-1 drug without asking, since it adds risk without clear benefit.
Sources
- Depommier, C., Everard, A., Druart, C., et al. (2019). Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study. Nature Medicine, 25(7), 1096-1103. https://doi.org/10.1038/s41591-019-0495-2" target="_blank" rel="noopener nofollow">https://doi.org/10.1038/s41591-019-0495-2">https://doi.org/10.1038/s41591-019-0495-2
- Eli Lilly and Company. (2026, April 1). FDA approves Lilly's Foundayo (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions [Press release]. https://www.prnewswire.com/news-releases/fda-approves-lillys-foundayo-orforglipron-the-only-glp-1-pill-for-weight-loss-that-can-be-taken-any-time-of-day-without-food-or-water-restrictions-302731485.html" target="_blank" rel="noopener nofollow">https://www.prnewswire.com/news-releases/fda-approves-lillys-foundayo-orforglipron-the-only-glp-1-pill-for-weight-loss-that-can-be-taken-any-time-of-day-without-food-or-water-restrictions-302731485.html">https://www.prnewswire.com/news-releases/fda-approves-lillys-foundayo-orforglipron-the-only-glp-1-pill-for-weight-loss-that-can-be-taken-any-time-of-day-without-food-or-water-restrictions-302731485.html
- Eli Lilly and Company. (2026). Zepbound® (tirzepatide) injection: Prescribing information (Revised 08/2026). DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b" target="_blank" rel="noopener nofollow">https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b">https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- Elahi Vahed, I., Shahir-Roudi, E., Nojumi, S., Golmohammadi, S., et al. (2026). The effect of berberine on obesity indices: A systematic review and meta-analysis. International Journal of Obesity, 50(1), 53-73. https://doi.org/10.1038/s41366-025-01943-x" target="_blank" rel="noopener nofollow">https://doi.org/10.1038/s41366-025-01943-x">https://doi.org/10.1038/s41366-025-01943-x
- Gholami, Z., & Paknahad, Z. (2025). The effect of psyllium consumption on anthropometric indices: A systematic review and dose-response meta-analysis of randomized controlled trials. Journal of Health, Population and Nutrition, 44(1), 372. https://doi.org/10.1186/s41043-025-01103-x" target="_blank" rel="noopener nofollow">https://doi.org/10.1186/s41043-025-01103-x">https://doi.org/10.1186/s41043-025-01103-x
- Mozaffarian, D., Agarwal, M., Aggarwal, M., et al. (2025). Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society. Obesity Pillars, 15, 100181. https://doi.org/10.1016/j.obpill.2025.100181" target="_blank" rel="noopener nofollow">https://doi.org/10.1016/j.obpill.2025.100181">https://doi.org/10.1016/j.obpill.2025.100181
- Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., et al. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism, 30, 72-130. https://doi.org/10.1016/j.molmet.2019.09.010" target="_blank" rel="noopener nofollow">https://doi.org/10.1016/j.molmet.2019.09.010">https://doi.org/10.1016/j.molmet.2019.09.010
- National Institute of Diabetes and Digestive and Kidney Diseases. (2018). Treatment for constipation. Retrieved October 6, 2026, from https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/treatment" target="_blank" rel="noopener nofollow">https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/treatment">https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/treatment
- National Institutes of Health, Office of Dietary Supplements. (2023, December 15). Vitamin B12: Fact sheet for consumers. Retrieved October 6, 2026, from https://ods.od.nih.gov/factsheets/VitaminB12-Consumer/" target="_blank" rel="noopener nofollow">https://ods.od.nih.gov/factsheets/VitaminB12-Consumer/">https://ods.od.nih.gov/factsheets/VitaminB12-Consumer/
- National Institutes of Health, Office of Dietary Supplements. (2022, May 18). Dietary supplements for weight loss: Fact sheet for health professionals. Retrieved October 6, 2026, from https://ods.od.nih.gov/factsheets/WeightLoss-HealthProfessional/" target="_blank" rel="noopener nofollow">https://ods.od.nih.gov/factsheets/WeightLoss-HealthProfessional/">https://ods.od.nih.gov/factsheets/WeightLoss-HealthProfessional/
- National Institutes of Health, Office of Dietary Supplements. (2023, September 14). Calcium: Fact sheet for consumers. Retrieved October 6, 2026, from https://ods.od.nih.gov/factsheets/Calcium-Consumer/" target="_blank" rel="noopener nofollow">https://ods.od.nih.gov/factsheets/Calcium-Consumer/">https://ods.od.nih.gov/factsheets/Calcium-Consumer/
- National Institutes of Health, Office of Dietary Supplements. (2022, November 8). Vitamin D: Fact sheet for consumers. Retrieved October 6, 2026, from https://ods.od.nih.gov/factsheets/VitaminD-Consumer/" target="_blank" rel="noopener nofollow">https://ods.od.nih.gov/factsheets/VitaminD-Consumer/">https://ods.od.nih.gov/factsheets/VitaminD-Consumer/
- National Institutes of Health, Office of Dietary Supplements. (n.d.). Dietary Supplement Label Database (search: "GLP-1"; 13 labels). Retrieved October 6, 2026, from https://dsld.od.nih.gov/" target="_blank" rel="noopener nofollow">https://dsld.od.nih.gov/">https://dsld.od.nih.gov/
- Novo Nordisk. (2026). Wegovy® (semaglutide) injection and tablets: Prescribing information (Revised 06/2026). DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b" target="_blank" rel="noopener nofollow">https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b">https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- Perraudeau, F., McMurdie, P., Bullard, J., et al. (2020). Improvements to postprandial glucose control in subjects with type 2 diabetes: A multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ Open Diabetes Research & Care, 8(1), e001319. https://doi.org/10.1136/bmjdrc-2020-001319" target="_blank" rel="noopener nofollow">https://doi.org/10.1136/bmjdrc-2020-001319">https://doi.org/10.1136/bmjdrc-2020-001319
- Shahinfar, H., Jayedi, A., Torabynasab, K., Payandeh, N., et al. (2023). Comparative effects of nutraceuticals on body weight in adults with overweight or obesity: A systematic review and network meta-analysis. Pharmacological Research, 196, 106944. https://doi.org/10.1016/j.phrs.2023.106944" target="_blank" rel="noopener nofollow">https://doi.org/10.1016/j.phrs.2023.106944">https://doi.org/10.1016/j.phrs.2023.106944
- U.S. Food and Drug Administration. (n.d.). FDA's concerns with unapproved GLP-1 drugs used for weight loss. Retrieved October 6, 2026, from https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss" target="_blank" rel="noopener nofollow">https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss">https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- U.S. Food and Drug Administration. (2021, March 4). 6 tip-offs to rip-offs: Don't fall for health fraud scams. Retrieved October 6, 2026, from https://www.fda.gov/consumers/consumer-updates/6-tip-offs-rip-offs-dont-fall-health-fraud-scams" target="_blank" rel="noopener nofollow">https://www.fda.gov/consumers/consumer-updates/6-tip-offs-rip-offs-dont-fall-health-fraud-scams">https://www.fda.gov/consumers/consumer-updates/6-tip-offs-rip-offs-dont-fall-health-fraud-scams
- U.S. Food and Drug Administration. (n.d.). 21 CFR 101.93: Certain types of statements for dietary supplements. eCFR. Retrieved October 6, 2026, from https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-101/subpart-F/section-101.93" target="_blank" rel="noopener nofollow">https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-101/subpart-F/section-101.93">https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-101/subpart-F/section-101.93
- Yu, Y., Liu, L., Wang, X., et al. (2010). Modulation of glucagon-like peptide-1 release by berberine: In vivo and in vitro studies. Biochemical Pharmacology, 79(7), 1000-1006. https://doi.org/10.1016/j.bcp.2009.11.017" target="_blank" rel="noopener nofollow">https://doi.org/10.1016/j.bcp.2009.11.017">https://doi.org/10.1016/j.bcp.2009.11.017





Comments